Medication adherence, access, and comorbidity management are critical to achieving target uric acid levels.
Priya Reddy, MD
Advertisement
Articles by Priya Reddy, MD
Advertisement
Latest Updated Articles
Personalizing Gout Management, with Priya Reddy, MDJune 13th 2025
Advertisement
Advertisement
Trending on Rheumatology Live
1
Nipocalimab, Telitacicept, and the Sjögren’s Disease Pipeline
2
Dazodalibep Eases Sjögren’s Dryness via CD40L Blockade: Ghaith Noaiseh, MD
3
Dazodalibep Lowers Sjögren’s Disease Activity: Ghaith Noaiseh, MD
4
INDIGO: Obexelimab Sustains IgG4-RD Flare Control, With John Stone, MD, MPH
5